Meeting
2023 ASCO Quality Care Symposium
Uptake of palliative care services in patients with non-small cell lung cancer receiving immune checkpoint inhibitor therapy: The Mayo Clinic Florida experience.
Authors
Tanmayi Pai
Mayo Clinic, Jacksonville, FL
Tanmayi Pai, Shenduo Li, Guilherme Sacchi de Camargo Correia, Osama M Mosalem, Nathaniel Edward Wiest, Emily Butts, Richard C Taylor, Yujie Zhao, Yanyan Lou, Rami Manochakian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Palliative and Supportive Care
Sub Track
Palliative Care
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 269)
DOI
10.1200/OP.2023.19.11_suppl.269
Abstract #
269
Poster Bd #
J4
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
AI-based radiomic biomarkers to predict PD-(L)1 immune checkpoint inhibitor response within PD-L1 high/low/negative expression categories in stage IV NSCLC.
First Author: George R. Simon
Poster
2024 ASCO Annual Meeting
PD-L1 expression in pulmonary sarcomatoid carcinoma and response to immunotherapy.
First Author: Lingzhi Hong
Poster
2023 ASCO Annual Meeting
Molecular characterization of resistance to immune checkpoint inhibitor and chemotherapy treatment in advanced non-small cell lung cancer.
First Author: Jordan Kardos
Poster
2023 ASCO Annual Meeting
Treatment at twilight: Is less more in the management of octogenarians with non-small cell lung cancer (NSCLC)?
First Author: Ethan Burns